Cefaclor: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 21: | Line 21: | ||
'''| [[Cefaclor clinical studies|Clinical Studies]]''' | '''| [[Cefaclor clinical studies|Clinical Studies]]''' | ||
'''| [[Cefaclor dosage and administration|Dosage and Administration]]''' | '''| [[Cefaclor dosage and administration|Dosage and Administration]]''' | ||
'''| [[Cefaclor how supplied|How Supplied]]''' | '''| [[Cefaclor how supplied|How Supplied]]''' | ||
'''| [[Cefaclor labels and packages|Labels and Packages]]''' | '''| [[Cefaclor labels and packages|Labels and Packages]]''' | ||
Revision as of 16:36, 24 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cefaclor, also known as cefachlor or cefaclorum (brand names Ceclor, Distaclor, Keflor, Raniclor), is a second-generation cephalosporin antibiotic used to treat certain infections caused by bacteria such as pneumonia and ear, lung, skin, throat, and urinary tract infections.
Category
Cephalosporin,Second-Generation
US Brand Names
Ceclor
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages